Biomea Fusion ($BMEA) saw a significant increase in stock price, reaching $12.01, up 25% from the previous close of $9.57. Other winners on the watchlist included Bristol-Myers Squibb ($BMY) up 6.72% and NIO up 15%. Analysts upgraded Biomea Fusion after the FDA lifted a clinical hold, leading to a surge in buy orders. Investors are holding onto Biomea Fusion stock, expecting it to reach $12 despite being pegged at $10 during market hours.

BMEA stock price is 3.9001. BMEA 52 Week low is None. BMEA 52 Week high is None. BMEA 200 day moving average is 7.3. It is currently trading below 200 day moving average. BMEA 50 day moving average is 4.93 which is above(bearish) the current price. RSI (relative strength index) of BMEA is 37.981 which is below (bearish) 70. Chaikin money flow (20 day) of BMEA is 0.129 which is above (bullish) 0.